唾液采集与诊断市场－全球产业规模、份额、趋势、机会及预测（依采集地点、应用、最终用户、地区及竞争格局划分，2021-2031年）

全球唾液采集和诊断市场预计将从 2025 年的 8.2218 亿美元成长到 2031 年的 11.0874 亿美元，复合年增长率为 5.11%。

此细分市场涵盖用于非侵入性采集和分析口腔生物体液以检测遗传标记、传染性病原体和一般健康指标的技术。推动该市场发展的关键因素是患者越来越倾向于选择无痛检测方式，以取代静脉抽血和鼻咽拭子，这种转变显着提高了检测依从性，尤其是在儿童和老年人群体中。此外，医疗保健分散化的趋势也促进了稳定型唾液采集试剂盒的使用。这些试剂盒可在室温下安全运输，方便在偏远地区进行检测和分子诊断。

儘管唾液诊断具有巨大潜力，但该行业在监管审批和生物标记检验方面仍面临许多挑战，尤其是在与既定血液标准进行比对方面。製造商难以证明检体均一性和诊断等效性，而这些正是获得上市前核准所必需的。美国牙科协会 (ADA) 强调了这项挑战的严峻性。 ADA 指出，截至 2024 年 10 月，将没有获得 FDA已通过核准的市售唾液诊断测试可用于评估牙周病、龋齿或头颈癌的风险，这凸显了目前存在的严格检验障碍。

市场驱动因素

由于诊断方法的去中心化和患者自我管理能力的提高，照护现场（POC​​）和居家检测的普及是市场扩张的关键驱动因素。这种发展趋势使得人们无需前往医疗机构即可自行检体进行感染疾病和一般健康状况的检测，从而有效避免了诸如后勤挑战和与检测相关的社会污名等障碍。监管机构正日益支持这些以患者为中心的模式，以扩大公共卫生覆盖范围并促进弱势群体早期发现疾病。例如，美国食品药物管理局（FDA）于2024年12月核准了OraQuick HIV自检检测套组，将其适用年龄下调至14至17岁的青少年。这标誌着检测工具正朝着更容易获取、更商业化的方向发展，旨在赋能年轻一代积极参与自身健康管理。

同时，唾液体学和生物标记发现领域的技术进步正大大拓展口腔液的效用，使其远远超越基本的病毒检测和药物筛检。研究人员正积极验证用于系统性疾病的新型检验，从而推动对多标靶平台的投资，这些平台可提供与血液检测相当的临床准确性。这项科学研究势头得到了政府的大力支持，美国国家牙科和颅颜研究所 (NIDCR) 在 2024 财年投资超过 300 万美元用于唾液诊断研究，以加速快速检测设备的开发。此类资金正在推动创新，例如频谱 Solutions 公司于 2024 年 3 月推出的「SimplyPERIO」唾液检测。此检测可从单一检体中识别 16 种口腔靶点，标誌着早期疗育正朝着高通量分子分析的方向发展。

市场挑战

全球唾液采集和诊断市场面临许多限制因素，包括严格的监管要求和复杂的临床检验（需证明其与血液检测标准等效）。製造商面临着很高的进入门槛，必须证明唾液衍生的生物标记与已建立的血浆和血清检测方法具有相同的诊断准确性和可靠性。这些严格的生物等效性需求导致研发週期长且成本高昂，迫使企业在商业化之前投入大规模资金进行对照研究。因此，核准流程的不确定性抑制了投资，并减缓了创新非侵入性检测技术的应用。

这些监管壁垒直接减少了可用检测项目的种类，并限制了患者获得先进诊断设备的机会。面对不断变化的合规标准和更高的证据要件，实验室往往选择减少检测项目，而不是耗费巨资核准程序。这种市场萎缩趋势反映在近期的产业调查结果中。根据2024年诊断和实验室医学协会（ADLM）的调查数据，超过50%的实验室表示，由于无法满足新的、更严格的监管标准，他们计划停止提供某些实验室自研检测项目。这表明，监管摩擦不仅阻碍了新进入者，也排除了现有解决方案，最终减缓了整个产业的发展。

市场趋势

基于唾液的液态生物检体技术的进步正拓展至预防肿瘤学领域，使得以往需要侵入性检查才能发现的全身性癌症能够以非侵入性方式进行识别。此方法利用唾液微生物组和RNA数据来检测特定的肿瘤标记和癌前指标，显着扩展了口腔液的应用范围，使其不再局限于局部疾病的诊断。为了支持这项进展，News-Medical.Net于2025年7月报道，Viome Life Sciences已与斯克里普斯研究所达成策略合作，将开展一项包含1000名参与者的临床试验，旨在开发一种用于早期结直肠癌预防的基于唾液的RNA检测方法。这项进展证实了口腔液是评估消化系统健康的可行介质，并有望减少对传统大肠镜检查的依赖，从而为初步筛检提供更多选择。

同时，唾液检测在药物基因体学领域的快速发展，正透过简化检体采集流程，实现精准用药管理，进而变革个人化医疗。越来越多的实验室采用基于唾液的基因组检测方案来研究患者的药物代谢，这有助于在神经病学和精神病学等复杂领域中最大限度地减少药物副作用。 Quest Diagnostics 于 2025 年 9 月推出了一项先进的药物基因组学检测服务，该服务可分析 17 个基因和 4 个 HLA 等位基因，为医生的处方策略提供支持，这标誌着市场正朝着这一方向发展。这项进步表明，将基于唾液的基因资讯整合到临床实践中具有商业性实用化，从而能够根据个体代谢特征制定个人化治疗方案。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球唾液采集与诊断市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依采集部位（腮腺采集、下颔腺/舌下腺采集、其他）
  • 按应用领域（疾病诊断、法医学应用、调查）
  • 依最终用户（牙医、诊断检查室、製药和生技公司、研究机构）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美唾液采集与诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲唾液采集与诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区唾液采集与诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东与非洲唾液采集与诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲唾液采集与诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球唾液采集与诊断市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• DNA Genotek
• Salimetrics
• OraSure
• Qiagen
• Thermo Fisher
• Abbott
• Nipro
• Zymo Research
• LabCorp
• BioDiagnostics Companies

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Saliva Collection & Diagnostics Market is projected to expand from a valuation of USD 822.18 Million in 2025 to USD 1108.74 Million by 2031, registering a CAGR of 5.11%. This sector covers technologies dedicated to the non-invasive collection and analysis of oral biofluids to detect genetic markers, infectious agents, and general health indicators. A primary catalyst for this market is the growing patient preference for painless alternatives to venous blood draws and nasopharyngeal swabs, a shift that notably improves adherence among children and the elderly. Additionally, the push toward decentralized healthcare is promoting the use of stabilized saliva kits, which allow for safe ambient transport to support remote testing and molecular diagnostics.

Despite this potential, the industry encounters significant hurdles related to regulatory clearance and the validation of biomarkers against established blood standards. Manufacturers struggle to prove sample consistency and diagnostic equivalence required for premarket approval. The severity of this challenge is highlighted by the American Dental Association, which noted that as of October 2024, there were no commercially available, FDA-approved salivary diagnostic tests for evaluating risks associated with periodontal disease, dental caries, or head and neck cancer, demonstrating the strict barriers to validation that currently exist.

Market Driver

The proliferation of point-of-care (POC) and at-home testing sectors is a major force driving market expansion by decentralizing diagnostic availability and giving patients more control. This evolution enables individuals to conduct self-sampling for infectious diseases and general wellness without needing to visit clinical sites, effectively bypassing obstacles like logistical difficulties and the stigma often associated with testing. Regulatory authorities are increasingly endorsing these patient-focused models to extend public health coverage and facilitate early detection in vulnerable groups. For example, the U.S. Food and Drug Administration (FDA) approved a supplement for the OraQuick HIV Self-Test in December 2024, lowering the usage age to include adolescents aged 14 to 17, signaling a shift toward accessible over-the-counter tools that allow younger populations to manage their health proactively.

Simultaneously, technological progress in salivaomics and biomarker discovery is expanding the utility of oral fluids well beyond basic viral detection or drug screening. Researchers are actively validating new analytes for systemic diseases, prompting investments in multi-target platforms that achieve clinical-grade accuracy similar to blood tests. This scientific drive is bolstered by significant government support; the National Institute of Dental and Craniofacial Research (NIDCR) invested over $3 million in salivary diagnostic research during fiscal year 2024 to accelerate the creation of rapid detection devices. Such funding is fueling innovation, as seen with Spectrum Solutions, which launched the SimplyPERIO saliva test in March 2024 to identify 16 specific oral targets from one sample, marking a shift toward high-throughput, molecular analysis for early intervention.

Market Challenge

The Global Saliva Collection & Diagnostics Market faces substantial constraints due to strict regulatory mandates and the intricate clinical validation needed to prove equivalence with blood-based benchmarks. Manufacturers encounter high entry barriers, as they must demonstrate that biomarkers derived from saliva provide the same diagnostic precision and reliability as established plasma or serum tests. This rigorous requirement for bioequivalence often prolongs development schedules and escalates expenses, compelling companies to fund extensive comparative studies prior to commercialization. Consequently, the uncertainty surrounding authorization pathways dampens investment enthusiasm and postpones the introduction of non-invasive testing innovations.

These regulatory obstacles directly reduce the variety of available tests and restrict patient access to advanced diagnostic instruments. Confronted with evolving compliance standards and higher evidentiary requirements, laboratories frequently choose to cut their test offerings rather than managing the expensive approval procedures. This trend of market shrinkage is reflected in recent industry findings; according to survey data from the Association for Diagnostics and Laboratory Medicine in 2024, over 50% of testing facilities intended to stop offering specific laboratory-developed tests because they could not meet new, more stringent regulatory criteria. This demonstrates how regulatory friction not only impedes new market entrants but also eliminates existing solutions, thereby retarding overall industry progress.

Market Trends

The evolution of saliva-based liquid biopsy is reaching into the realm of preventative oncology, allowing for the non-invasive identification of systemic cancers that once necessitated invasive techniques. This approach leverages salivary microbiome and RNA data to detect specific tumor markers and precancerous indicators, significantly expanding the application of oral fluids beyond localized disease diagnosis. Validating this progression, News-Medical.Net reported in July 2025 that Viome Life Sciences formed a strategic alliance with Scripps Research to execute a clinical trial with 1,000 participants, aiming to create a saliva-based RNA test for early colorectal cancer prevention. This development confirms oral fluids as a feasible medium for evaluating gastrointestinal health, offering a potential reduction in the dependency on conventional colonoscopies for initial screenings.

In parallel, the growth of saliva testing within pharmacogenomics is transforming personalized medicine by enabling precise medication management through easier sample collection methods. Laboratories are increasingly adopting saliva-based genomic panels to examine how patients metabolize medications, helping to minimize adverse reactions in complex fields such as neurology and psychiatry. Highlighting this market shift, Quest Diagnostics introduced an advanced pharmacogenomic laboratory service in September 2025 capable of analyzing 17 genes and 4 HLA alleles to inform physician prescribing strategies. This advancement emphasizes the increasing commercial practicality of utilizing saliva to integrate genetic insights into standard clinical practices, ensuring that treatments are customized to individual metabolic profiles.

Key Market Players

• DNA Genotek
• Salimetrics
• OraSure
• Qiagen
• Thermo Fisher
• Abbott
• Nipro
• Zymo Research
• LabCorp
• BioDiagnostics Companies

Report Scope

In this report, the Global Saliva Collection & Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Saliva Collection & Diagnostics Market, By Site of Collection

• Parotid Gland Collection
• Submandibular/Sublingual Gland Collection
• Others

Saliva Collection & Diagnostics Market, By Application Type

• Disease Diagnostics
• Forensic Applications
• Research

Saliva Collection & Diagnostics Market, By End User

• Dentistry
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes

Saliva Collection & Diagnostics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Saliva Collection & Diagnostics Market.

Available Customizations:

Global Saliva Collection & Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Saliva Collection & Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection, Others)
  • 5.2.2. By Application Type (Disease Diagnostics, Forensic Applications, Research)
  • 5.2.3. By End User (Dentistry, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Saliva Collection & Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Site of Collection
  • 6.2.2. By Application Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Saliva Collection & Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Site of Collection
      • 6.3.1.2.2. By Application Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Saliva Collection & Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Site of Collection
      • 6.3.2.2.2. By Application Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Saliva Collection & Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Site of Collection
      • 6.3.3.2.2. By Application Type
      • 6.3.3.2.3. By End User

7. Europe Saliva Collection & Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Site of Collection
  • 7.2.2. By Application Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Saliva Collection & Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Site of Collection
      • 7.3.1.2.2. By Application Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Saliva Collection & Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Site of Collection
      • 7.3.2.2.2. By Application Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Saliva Collection & Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Site of Collection
      • 7.3.3.2.2. By Application Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Saliva Collection & Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Site of Collection
      • 7.3.4.2.2. By Application Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Saliva Collection & Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Site of Collection
      • 7.3.5.2.2. By Application Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Saliva Collection & Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Site of Collection
  • 8.2.2. By Application Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Saliva Collection & Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Site of Collection
      • 8.3.1.2.2. By Application Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Saliva Collection & Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Site of Collection
      • 8.3.2.2.2. By Application Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Saliva Collection & Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Site of Collection
      • 8.3.3.2.2. By Application Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Saliva Collection & Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Site of Collection
      • 8.3.4.2.2. By Application Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Saliva Collection & Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Site of Collection
      • 8.3.5.2.2. By Application Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Saliva Collection & Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Site of Collection
  • 9.2.2. By Application Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Saliva Collection & Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Site of Collection
      • 9.3.1.2.2. By Application Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Saliva Collection & Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Site of Collection
      • 9.3.2.2.2. By Application Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Saliva Collection & Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Site of Collection
      • 9.3.3.2.2. By Application Type
      • 9.3.3.2.3. By End User

10. South America Saliva Collection & Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Site of Collection
  • 10.2.2. By Application Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Saliva Collection & Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Site of Collection
      • 10.3.1.2.2. By Application Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Saliva Collection & Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Site of Collection
      • 10.3.2.2.2. By Application Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Saliva Collection & Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Site of Collection
      • 10.3.3.2.2. By Application Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Saliva Collection & Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. DNA Genotek
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Salimetrics
• 15.3. OraSure
• 15.4. Qiagen
• 15.5. Thermo Fisher
• 15.6. Abbott
• 15.7. Nipro
• 15.8. Zymo Research
• 15.9. LabCorp
• 15.10. BioDiagnostics Companies

16. Strategic Recommendations

17. About Us & Disclaimer